Hydroxytamoxifen interaction with human erythrocyte membrane and induction of permeabilization and subsequent hemolysis
- 31 December 2001
- journal article
- Published by Elsevier in Toxicology in Vitro
- Vol. 15 (6) , 615-622
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structureBiochimica et Biophysica Acta (BBA) - Biomembranes, 2000
- Tamoxifen Inhibits Induction of the Mitochondrial Permeability Transition by Ca2+and Inorganic PhosphateToxicology and Applied Pharmacology, 1998
- The effect of the anticancer drugs tamoxifen and hydroxytamoxifen on the calcium pump of isolated sarcoplasmic reticulum vesiclesToxicology in Vitro, 1996
- Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activityBiochemical Pharmacology, 1994
- The active metabolite hydroxytamoxifen of the anticancer drug tamoxifen induces structural changes in membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1993
- The anticancer drug tamoxifen induces changes in the physical properties of model and native membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1993
- Tamoxifen-associated hepatocellular damage and agranulocytosisThe Lancet, 1992
- A reliable and rapid procedure to estimate drug partitioning in biomembranesBiochemical and Biophysical Research Communications, 1991
- High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metaboliteMolecular and Cellular Endocrinology, 1980
- Erythrocyte membrane cholesterol: An explanation of the aging effect on the rate of hemolysisLife Sciences, 1980